Last week at the ISER 2023 biennal meeting, users of Imagine Eyes’ retinal imaging devices have shared their work and findings in several lectures. We are grateful to them for the great exposure given to our products!
Multimodal imaging of transplanted iPS-derived RPE cells in a patient with AMD
Seiji Takagi (Kobe Eye Center, Japan) reported updates from the first implementation of a rtx1 AO camera in a therapeutic study. He showed how rtx1 enabled investigators to confirm the structural stability of transplanted retinal epithelium cells, as part of the safety assessment.
High Resolution and Multimodal Structural Phenotyping of Intermediate and Advanced Non-neovascular Age-related Macular Degeneration
Chiara Eandi (Vision Institute and Quinze-Vingts National Ophthalmology Hospital, France) presented a bi-centric study conducted in Paris and University of Pittsburgh. In more than 100 patients, rtx1 AO cameras revealed distinct cellular-level phenotypes in non-neovascular AMD.
High resolution imaging of healthy and pathological retina using an adaptive optics camera with transscleral flood illumination
Kiyoko Gocho (Inserm and Quinze-Vingts National Ophthalmology Hospital, France) presented how a new option available for rtx1 AO cameras – the TFI option – provides unprecedented information on the RPE layer and its alterations in macular degenerations.